Operating Data

FibroGen Inc (FGEN)

$ 18.57
-0.24 (-1.28%)
Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Revenue 102.17137.60180.83179.58125.67212.96256.58176.32200.01226.88257.36291.93331.16
Revenue (%)
EBITDA -2.87-45.63-71.95-47.61-116.51-80.13-67.86-169.83-88.85-100.78-114.32-129.68-147.11
EBITDA (%)
EBIT -7.95-50.10-77.62-53.65-122.61-86.69-89.31-191.88-99.73-113.13-128.33-145.57-165.13
EBIT (%)
Depreciation 5.084.475.686.046.106.5621.4522.0510.8812.341415.8818.02
Depreciation (%)




EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT)
EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income)
EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization
EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company
(1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments),
(2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill)
(3*) collections of assets (by ignoring depreciation of assets)
(4*) different takeover histories (by ignoring amortization often stemming from goodwill)